Design and Molecular Docking Study of Novel 2H-Chromene Derivatives as Potential Cyclooxygenase-2 (COX-2) Inhibitors

Authors

  • Zohra Guadguad
  • Regadia Aissaoui
  • Ali Brahimi
  • Mokhtar Boualem Lahrech
  • Sofiane Makhlouf
  • Abdelkarim Brahimi

DOI:

https://doi.org/10.22399/ijcesen.5390

Keywords:

Chromene derivatives, COX-2 inhibitors, Molecular docking, AutoDock Vina, Structure-activity relationship

Abstract

Cyclooxygenase-2 (COX-2) is a key inducible enzyme of the arachidonic acid cascade and a well-validated target for anti-inflammatory drug design. The 2H-chromene scaffold is a privileged heterocyclic core associated with anti-inflammatory, antioxidant and anticancer activities. In this work, five 2-methyl-2H-chromene derivatives (C1-C5), computationally designed in silico (not yet synthesized or experimentally characterized) and bearing an open-chain acetyl/ester moiety (C1), spiro-fused cyclopentanone (C2) and cyclohexanone (C3) rings, and 7-chloro (C4) and 7-bromo (C5) substituents, were evaluated in silico as potential COX-2 inhibitors. Molecular docking was performed with AutoDock Vina implemented in PyRx 0.8 against the crystal structure of human COX-2 co-crystallized with rofecoxib (PDB ID: 5KIR), using celecoxib as the reference inhibitor. All compounds displayed negative binding free energies (−6.7 to −7.3 kcal/mol), confirming spontaneous accommodation within the COX-2 active site, although none exceeded celecoxib (−7.9 kcal/mol). Compound C4 (7-chloro derivative) showed the highest affinity among the series (−7.3 kcal/mol) and the richest interaction network (LEU472, MET471, PRO86, SER119, LYS83, VAL89, TYR355, VAL116, LEU93). Compound C2 (−7.0 kcal/mol) uniquely engaged in a π–π T-shaped interaction with TYR115. Compounds C1, C3 and C5 shared an identical score (−6.7 kcal/mol), stabilized mainly via π-alkyl contacts with VAL89, VAL116 and LEU93. These results establish a preliminary structure-activity relationship in which halogenation and spiro-ring fusion enhance ligand accommodation within the COX-2 pocket, with C4 emerging as the most promising candidate for further experimental validation.

References

[1] Vane, J. R., & Botting, R. M. (1998). Anti-inflammatory drugs and their mechanism of action. Inflammation Research, 47(Suppl 2), S78-S87. https://doi.org/10.1007/s000110050284

[2] Mitchell, J. A., & Warner, T. D. (1999). Cyclo-oxygenase-2: Pharmacology, physiology, biochemistry and relevance to NSAID therapy. British Journal of Pharmacology, 128(6), 1121-1132. https://doi.org/10.1038/sj.bjp.0702897

[3] FitzGerald, G. A., & Patrono, C. (2001). The coxibs, selective inhibitors of cyclooxygenase-2. New England Journal of Medicine, 345(6), 433-442. https://doi.org/10.1056/NEJM200108093450607

[4] Kumar, S., Pathak, P., & Gupta, A. (2020). Chromene derivatives as potential anti-inflammatory agents: A review. Current Medicinal Chemistry, 27(28), 4640-4671. https://doi.org/10.2174/0929867326666190124121006

[5] Shaaban, M. A., Shaker, Y. M., Lasheen, D. S., Kamel, G., Ibrahem, R. A., Yousef, R. G., & Abdelazeem, A. H. (2020). Design, synthesis and biological evaluation of chromene-based compounds as selective COX-2 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 1251-1264. https://doi.org/10.1080/14756366.2020.1772249

[6] Rahman, M. A., Siddiqui, N., Ali, R., & Shamsuddin, S. (2018). Chromene scaffold: A review of its importance in biomedical research. Medicinal Chemistry, 14(1), 2-18. https://doi.org/10.2174/1573406413666170609084440

[7] Orlando, B. J., & Malkowski, M. G. (2016). Crystal structure of rofecoxib bound to human cyclooxygenase-2. Biochemistry, 55(34), 4922-4931. https://doi.org/10.1021/acs.biochem.6b00681

[8] Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455-461. https://doi.org/10.1002/jcc.21334

[9] Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology, 1263, 243-250. https://doi.org/10.1007/978-1-4939-2269-7_19

[10] BIOVIA, Dassault Systemes. (2021). Discovery Studio Visualizer, v21.1.0.20298. San Diego: Dassault Systemes.

[11] Aissaoui, R., Khalifa, A., Mokhtari, Z., Benhamida, A., Kussay, K., & Gherraf, N. (2019). Preparation of Polyfunctionalized 1,2-Benzylated Derivatives from O-Salicylic Aldehyde and beta-Diketones. Journal of Biochemical Technology, 10(1), 24-32.

[12] Belaud-Rotureau, M., Le, T. T., Phan, T. H. T., Nguyen, T. H., Aissaoui, R., Gohier, F., Derdour, A., Nourry, A., Castanet, A.-S., Nguyen, K. P. P., & Mortier, J. (2010). Synthesis of N-Aryl and N-Alkyl Anthranilic Acids via SNAr Reaction of Unprotected 2-Fluoro- and 2-Methoxybenzoic Acids by Lithioamides. Organic Letters, 12(10), 2406-2409. https://doi.org/10.1021/ol1007586

[13] Aissaoui, R., Nourry, A., Coquel, A., Dao, T. T. H., Derdour, A., Helesbeux, J.-J., Duval, O., Castanet, A.-S., & Mortier, J. (2012). ortho-Lithium/Magnesium Carboxylate-Driven Aromatic Nucleophilic Substitution Reactions on Unprotected Naphthoic Acids. The Journal of Organic Chemistry, 77(1), 718-724. https://doi.org/10.1021/jo202017z

[14] Lakkadi, A., Vuppala, S., Nampally, V., Kim, J., Kim, K., Jang, J., & Tigulla, P. (2024). Development of novel chromones as antioxidant COX-2 inhibitors: in vitro, QSAR, DFT, molecular docking, and molecular dynamics studies. Journal of Biomolecular Structure and Dynamics, 42(6), 2793-2808. https://doi.org/10.1080/07391102.2023.2212785

[15] Pan, T., He, M., Deng, L., Li, J., Fan, Y., Hao, X., & Mu, S. (2023). Design, Synthesis, and Evaluation of the COX-2 Inhibitory Activities of New 1,3-Dihydro-2H-indolin-2-one Derivatives. Molecules, 28(12), 4668. https://doi.org/10.3390/molecules28124668

[16] Kurbanova, M. M., Maharramov, A. M., Sadigova, A. Z., Gurbanova, F. Z., Mali, S. N., Al-Salahi, R., El Bakri, Y., & Lai, C.-H. (2023). Synthesis, Characterization, DFT, and In Silico Investigation of Two Newly Synthesized beta-Diketone Derivatives as Potent COX-2 Inhibitors. Bioengineering, 10(12), 1361. https://doi.org/10.3390/bioengineering10121361

[17] Aissaoui, R., Rebizi, M. N., Boussaid, K., Lanez, E., & Lanez, T. (2025). In Silico Assessment of the Insecticidal and Herbicidal Potential of Silichristin Isolated from Silybum Marianum: Pharmacokinetic-Toxicity Properties, Molecular Docking, and Molecular Dynamics. Turkish Computational and Theoretical Chemistry, 9(2), 111-124. https://doi.org/10.33435/tcandtc.1527511

[18] Belkheiri, K. I., Aissaoui, R., Brahimi, A., Lahrech, M. B., Hakem, A., Naouri, A., Ameraoui, R., & Belkhalfa, H. (2023). Synthesis of Novel Spiro-Heterocyclic System by Diels-Alder Reaction Catalysed with TiCl4 for [4+2] Cycloaddition. Journal of Pharmaceutical Negative Results, 14(Regular Issue 03), 3569-3576. https://doi.org/10.47750/pnr.2023.14.03.443

Downloads

Published

2026-07-06

How to Cite

Zohra Guadguad, Regadia Aissaoui, Ali Brahimi, Mokhtar Boualem Lahrech, Sofiane Makhlouf, & Abdelkarim Brahimi. (2026). Design and Molecular Docking Study of Novel 2H-Chromene Derivatives as Potential Cyclooxygenase-2 (COX-2) Inhibitors. International Journal of Computational and Experimental Science and Engineering, 12(3). https://doi.org/10.22399/ijcesen.5390

Issue

Vol. 12 No. 3 (2026): IJCESEN

Section

Research Article

License

Copyright (c) 2026 International Journal of Computational and Experimental Science and Engineering

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.